These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31694589)

  • 21. Factors affecting guideline adherence in the initial treatment of non-muscle invasive bladder cancer: Retrospective study in a French peripheral hospital.
    Jeglinschi S; Schirmann A; Durand M; Sanchez S; Larré S; Léon P
    Prog Urol; 2020 Jan; 30(1):26-34. PubMed ID: 31813714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of a Questionnaire-Based Study on Guideline Adherence Regarding Adjuvant Treatment Recommendations for Patients with Non-Muscle-Invasive Bladder Cancer: Just a Disturbing Sidelight?].
    Lebentrau S; Lebentrau J; May M; Wick AK; Mathew M; Schostak M
    Aktuelle Urol; 2016 Sep; 47(5):408-13. PubMed ID: 27299426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A critical appraisal of urolithiasis clinical practice guidelines using the AGREE II instrument.
    Zou B; Zhou Y; He Z; Zhou X; Dong S; Zheng X; Xu R; Duan X; Zeng G
    Transl Androl Urol; 2023 Jun; 12(6):977-988. PubMed ID: 37426603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reported use of intravesical therapy for non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Advocacy Network (BCAN) survey.
    Nielsen ME; Smith AB; Pruthi RS; Guzzo TJ; Amiel G; Shore N; Lotan Y
    BJU Int; 2012 Oct; 110(7):967-72. PubMed ID: 22487336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality appraisal of clinical practice guidelines addressing massage interventions using the AGREE II instrument.
    Fan M; Liu A; Lu T; Zhou X; Tian C; Liu B; Xie Q; Cai J; Yin L; Ge L; Wu D
    Syst Rev; 2024 Mar; 13(1):83. PubMed ID: 38459534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The quality of clinical practice guidelines in traditional medicine in Korea: appraisal using the AGREE II instrument.
    Choi TY; Choi J; Lee JA; Jun JH; Park B; Lee MS
    Implement Sci; 2015 Jul; 10():104. PubMed ID: 26216349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical practice guidelines for the treatment and management of low back pain: A systematic review of quantity and quality.
    Ng JY; Mohiuddin U; Azizudin AM
    Musculoskelet Sci Pract; 2021 Feb; 51():102295. PubMed ID: 33444892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality assessment of peripheral artery disease clinical guidelines.
    Barriocanal AM; López A; Monreal M; Montané E
    J Vasc Surg; 2016 Apr; 63(4):1091-8. PubMed ID: 27016858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel.
    Sylvester RJ; Rodríguez O; Hernández V; Turturica D; Bauerová L; Bruins HM; Bründl J; van der Kwast TH; Brisuda A; Rubio-Briones J; Seles M; Hentschel AE; Kusuma VRM; Huebner N; Cotte J; Mertens LS; Volanis D; Cussenot O; Subiela Henríquez JD; de la Peña E; Pisano F; Pešl M; van der Heijden AG; Herdegen S; Zlotta AR; Hacek J; Calatrava A; Mannweiler S; Bosschieter J; Ashabere D; Haitel A; Côté JF; El Sheikh S; Lunelli L; Algaba F; Alemany I; Soria F; Runneboom W; Breyer J; Nieuwenhuijzen JA; Llorente C; Molinaro L; Hulsbergen-van de Kaa CA; Evert M; Kiemeney LALM; N'Dow J; Plass K; Čapoun O; Soukup V; Dominguez-Escrig JL; Cohen D; Palou J; Gontero P; Burger M; Zigeuner R; Mostafid AH; Shariat SF; Rouprêt M; Compérat EM; Babjuk M; van Rhijn BWG
    Eur Urol; 2021 Apr; 79(4):480-488. PubMed ID: 33419683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality appraisal of clinical practice guidelines for diabetes mellitus published in China between 2007 and 2017 using the AGREE II instrument.
    Gao Y; Wang J; Luo X; Song X; Liu L; Ke L; Liao Z; Wang D; Mu Y; Chen Y; Estill JAM
    BMJ Open; 2019 Sep; 9(9):e022392. PubMed ID: 31488461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics and quality of clinical practice guidelines for diabetic kidney disease: a systematic review.
    Yuhuang W; Le Z; Zhengshan Z; Zhi Y; Xiyao LI; Luying S; Xing L
    J Tradit Chin Med; 2024 Jun; 44(3):609-619. PubMed ID: 38767646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approaches to Non-Muscle-Invasive Bladder Cancer.
    Slovacek H; Zhuo J; Taylor JM
    Curr Oncol Rep; 2021 Jul; 23(9):105. PubMed ID: 34269918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Management of Newly-Diagnosed Non-muscle Invasive Bladder Cancer in Veterans Integrated Services Network 02 of the Veterans Health Administration.
    Caputo JM; Moran G; Muller B; Keller AT; Li G; Anderson CB
    Mil Med; 2020 Feb; 185(1-2):276-281. PubMed ID: 31294791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Appraising the quality of clinical practice guidelines in traditional Chinese medicine using AGREE II instrument: A systematic review.
    Yao L; Chen Y; Wang X; Shi X; Wang Y; Guo T; Yang K
    Int J Clin Pract; 2017 May; 71(5):. PubMed ID: 28382763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical practice guidelines for the management of community-acquired pneumonia: A critical appraisal using the AGREE II instrument.
    Triana AJ; Molinares JL; Del Rio-Pertuz G; Meza JL; Ariza-Bolívar O; Robledo-Solano A; Acosta-Reyes J
    Int J Clin Pract; 2020 May; 74(5):e13478. PubMed ID: 31927777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Practice Guidelines for Hypertension: Evaluation of Quality Using the AGREE II Instrument.
    Zhang X; Zhao K; Bai Z; Yu J; Bai F
    Am J Cardiovasc Drugs; 2016 Dec; 16(6):439-451. PubMed ID: 27580999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Systematic Review of Clinical Practice Guidelines for Identification and Management of Frailty.
    Mehta P; Lemon G; Hight L; Allan A; Li C; Pandher SK; Brennan J; Arumugam A; Walker X; Waters DL
    J Nutr Health Aging; 2021; 25(3):382-391. PubMed ID: 33575732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group.
    Tan WS; Steinberg G; Witjes JA; Li R; Shariat SF; Roupret M; Babjuk M; Bivalacqua TJ; Psutka SP; Williams SB; Cookson MS; Palou J; Kamat AM
    Eur Urol Oncol; 2022 Oct; 5(5):505-516. PubMed ID: 35718695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving compliance with guidelines may lead to favorable clinical outcomes for patients with non-muscle-invasive bladder cancer: A retrospective multicenter study.
    Sato T; Sano T; Kawamura S; Ikeda Y; Orikasa K; Tanaka T; Kyan A; Ota S; Tokuyama S; Saito H; Mitsuzuka K; Yamashita S; Arai Y; Kobayashi T; Ito A
    Int J Urol; 2023 Dec; 30(12):1155-1163. PubMed ID: 37665144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reducing recurrence in non-muscle-invasive bladder cancer by systematically implementing guideline-based recommendations: effect of a prospective intervention in primary bladder cancer patients.
    Sörenby A; Baseckas G; Bendahl PO; Brändstedt J; Håkansson U; Nilsson S; Patschan O; Tinzl M; Wokander M; Liedberg F; Gudjonsson S
    Scand J Urol; 2019; 53(2-3):109-115. PubMed ID: 31064253
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.